Podocyte stress hypertrophy and depletion

足细胞应激肥大和耗竭

基本信息

项目摘要

DESCRIPTION (provided by applicant): Glomerulosclerosis is the common pathologic process responsible for 90% of End Stage Kidney Disease (ESKD) associated with diabetes, hypertension, IgA nephropathy, Focal Segmental Glomerulosclerosis (FSGS), lupus and other glomerular diseases. Together these diseases cost approximately $18 billion per year in the US, and carry high morbidity and mortality. They are increasing in prevalence and are commoner in minority populations. They affect both children and adults, although ESKD is particularly a disease of aging with average onset of ESKD treatment at 64 years. The central hypothesis underlying this work is that glomerulosclerosis is caused by depletion of one of the glomerular cell types, the podocyte. During the prior grant cycle we developed a new transgenic model system in the rat where we can deplete podocytes by an amount and at a time of prior choosing. We show that podocyte depletion does indeed cause all the features of FSGS in a dose-dependant manner. Second we have developed a new method for counting podocytes in glomeruli. Third, we have shown how glomerular enlargement during aging on a high calorie diet causes relative podocyte depletion that predisposes to glomerulosclerosis, and how this can be prevented by calorie restiction. Because we know that hypertension is commonly associated with glomerulosclerosis and progression of glomerulosclerosis to ESKD, these new tools and concepts will be used to test specific hypotheses relevant to human glomerulosclerosis: Aim 1: Podocyte depletion itself causes systemic hypertension and mesangial expansion, an important pathologic component of early glomerulosclerosis in man. Aim 2: Test the hypothesis that limitation of the ability of the podocyte to increase in size makes the glomerulus more susceptible to glomerulosclerosis, while enhancement of podocyte's ability to increase in size prevents glomerulosclerosis, by using transgenes of the mTOR pathway of cell size control to modulate podocyte size. Aim 3: Validate the novel concepts of podocyte alteration in phenotype in response to stress that we have termed "adaptation" and "decompensation" in two rat models of glomerulosclerosis, with the underlying concept that understanding the biology of this process will allow us to develop markers for human podocyte stress as well as new approaches to treat and prevent podocyte stress before it results in loss of podocytes and consequent glomerulosclerosis.
描述(由申请人提供):肾小球硬化是导致与糖尿病,高血压,IGA肾病,局灶性分段性肾小球硬化症(FSGS),狼疮和其他肾小球疾病相关的90%末期肾脏疾病(ESKD)的常见病理过程。这些疾病在美国每年的损失约为180亿美元,并具有高发病率和死亡率。他们的患病率正在增加,在少数族裔人口中更为常见。它们会影响儿童和成人,尽管ESKD尤其是一种衰老的疾病,而在64岁时的ESKD平均治疗开始。这项工作的基础假设是肾小球硬化是由肾小球细胞类型之一(Podocyte)耗尽引起的。在先前的赠款周期中,我们在大鼠中开发了一个新的转基因模型系统,在该系统中,我们可以在选择的时间内耗尽了足够的足细胞。我们表明,足细胞的耗竭确实确实以剂量依赖性的方式引起了FSG的所有特征。其次,我们开发了一种在肾小球中计数足细胞的新方法。第三,我们已经展示了高热量饮食中衰老过程中的肾小球增大如何导致相对足细胞耗尽,使肾小球硬化症易受到倾向,以及如何通过降低卡路里来预防。 Because we know that hypertension is commonly associated with glomerulosclerosis and progression of glomerulosclerosis to ESKD, these new tools and concepts will be used to test specific hypotheses relevant to human glomerulosclerosis: Aim 1: Podocyte depletion itself causes systemic hypertension and mesangial expansion, an important pathologic component of early glomerulosclerosis in man.目标2:检验以下假设:足细胞增加大小的能力使肾小球更容易受到肾小球硬化的影响,同时增强了Podocyte增加尺寸的能力,可以通过使用细胞尺寸控制的MTOR途径来控制Podocyte尺寸的MTOR途径。目标3:在两种大鼠的肾小球硬化模型中,验证表型中的足细胞改变的新概念,以应对压力,并以此为基础的概念,即理解这一过程的生物学,使我们能够为人类的Podocyte压力和预防损失带来的损失和预防效果的损失,并导致podocyte的损失,并导致Podocyte的损失。肾小球硬化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROGER Charles WIGGINS其他文献

ROGER Charles WIGGINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROGER Charles WIGGINS', 18)}}的其他基金

Podocyte Markers in Human Glomerular Diseases
人类肾小球疾病中的足细胞标志物
  • 批准号:
    8859222
  • 财政年份:
    2015
  • 资助金额:
    $ 7.04万
  • 项目类别:
Podocyte Markers in Human Glomerular Diseases
人类肾小球疾病中的足细胞标志物
  • 批准号:
    9137679
  • 财政年份:
    2015
  • 资助金额:
    $ 7.04万
  • 项目类别:
The University of Michigan George M O'Brien Renal Core Center
密歇根大学乔治·M·奥布莱恩肾脏核心中心
  • 批准号:
    7679129
  • 财政年份:
    2008
  • 资助金额:
    $ 7.04万
  • 项目类别:
The University of Michigan George M O'Brien Renal Core Center
密歇根大学乔治·M·奥布莱恩肾脏核心中心
  • 批准号:
    7533046
  • 财政年份:
    2008
  • 资助金额:
    $ 7.04万
  • 项目类别:
Pilot 1
试点1
  • 批准号:
    7510291
  • 财政年份:
    2007
  • 资助金额:
    $ 7.04万
  • 项目类别:
Pilot 2
飞行员2
  • 批准号:
    7510294
  • 财政年份:
    2007
  • 资助金额:
    $ 7.04万
  • 项目类别:
Core A
核心A
  • 批准号:
    7510290
  • 财政年份:
    2007
  • 资助金额:
    $ 7.04万
  • 项目类别:
Project 3
项目3
  • 批准号:
    7501076
  • 财政年份:
    2007
  • 资助金额:
    $ 7.04万
  • 项目类别:
IDENTIFICATION AND CHARACTERIZATION OF THE GLEPP1/RECEPTOR LIGAND
GLEPP1/受体配体的鉴定和表征
  • 批准号:
    6338751
  • 财政年份:
    2000
  • 资助金额:
    $ 7.04万
  • 项目类别:
IDENTIFICATION AND CHARACTERIZATION OF THE GLEPP1/RECEPTOR LIGAND
GLEPP1/受体配体的鉴定和表征
  • 批准号:
    6201859
  • 财政年份:
    1999
  • 资助金额:
    $ 7.04万
  • 项目类别:

相似国自然基金

来源和老化过程对大气棕碳光吸收特性及环境气候效应影响的模型研究
  • 批准号:
    42377093
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
内源DOM介导下微塑料的老化过程及对植物的影响机制
  • 批准号:
    42377233
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
老化过程对沙尘辐射效应和反馈机制的影响研究
  • 批准号:
    42375107
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
生物炭原位修复底泥PAHs的老化特征与影响机制
  • 批准号:
    42307107
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
河口潮滩中轮胎磨损颗粒的光老化特征及对沉积物氮素转化的影响与机制
  • 批准号:
    42307479
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 7.04万
  • 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 7.04万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 7.04万
  • 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
  • 批准号:
    10465010
  • 财政年份:
    2023
  • 资助金额:
    $ 7.04万
  • 项目类别:
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
  • 批准号:
    10537391
  • 财政年份:
    2023
  • 资助金额:
    $ 7.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了